Karolina Ollik, “NEW DISEASE-MODIFYING THERAPIES IN ALZHEIMER’S DISEASE: A CLINICAL REVIEW OF LECANEMAB AND DONANEMAB”, IJITSS, vol. 2, no. 1(49), Mar. 2026, doi: 10.31435/ijitss.1(49).2026.4885.